Document Detail


Production, purification and functional validation of human secreted amyloid precursor proteins for use as neuropharmacological reagents.
MedLine Citation:
PMID:  17537517     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The secreted fragment of the amyloid precursor protein (sAPPalpha) generated following cleavage by alpha-secretase is an important mediator of cell function and is both neurotrophic and neuroprotective. HEK 293T cells have been stably integrated with a fragment of the APP gene to produce and secrete either sAPPalpha, or the alternative cleavage product sAPPbeta. Heparin binding domains on the proteins have been utilised to develop a one-step fast-performance-liquid-chromatography (FPLC) purification of sAPPs from the conditioned media. Immunoblotting analyses with a sAPP specific antibody coupled with highly sensitive silver staining techniques have validated the expression and purification strategy. Functional activity of the purified fragments was demonstrated by their ability to protect COS-7 and SH-SY5Y (neuroblastoma) cells against the adverse effects of glucose deprivation in a cell viability assay. The purified sAPPs also activated the NFkappaB transcription factor in COS-7 cells transfected with a luciferase reporter plasmid, with sAPPalpha the more potent activator as expected. The simple protocol to produce these mammalian expressed proteins will facilitate their use as potential neuropharmacological reagents in the elucidation of biochemical pathways modulated by sAPPs, and in the study of Alzheimer's disease mechanisms in general.
Authors:
Paul R Turner; Katie Bourne; Daniel Garama; Alan Carne; Wickliffe C Abraham; Warren P Tate
Related Documents :
3148547 - Correlation of presentation of insulin with surface i-ad and a alpha and a beta mrna ex...
17537517 - Production, purification and functional validation of human secreted amyloid precursor ...
11406297 - Extracellular-regulated kinase controls beta-amyloid precursor protein mrna decay.
18483477 - Amyloid precursor protein expression is upregulated in adipocytes in obesity.
16207757 - The werewolf myb protein directly regulates caprice transcription during cell fate spec...
16673357 - Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Validation Studies     Date:  2007-04-06
Journal Detail:
Title:  Journal of neuroscience methods     Volume:  164     ISSN:  0165-0270     ISO Abbreviation:  J. Neurosci. Methods     Publication Date:  2007 Aug 
Date Detail:
Created Date:  2007-06-25     Completed Date:  2007-09-27     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  7905558     Medline TA:  J Neurosci Methods     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  68-74     Citation Subset:  IM    
Affiliation:
Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alzheimer Disease / drug therapy,  metabolism,  physiopathology
Amyloid beta-Protein Precursor / chemistry*,  isolation & purification*,  pharmacology
Animals
Antibody Specificity / immunology
COS Cells
Cell Culture Techniques
Cell Line
Cell Line, Tumor
Cell Survival / drug effects,  physiology
Cercopithecus aethiops
Chromatography, Liquid / methods*
Humans
Immunoblotting / methods
Neurochemistry / methods*
Neuroprotective Agents / chemistry*,  isolation & purification*,  pharmacology
Protein Structure, Tertiary / physiology
Silver Staining / methods
Transcriptional Activation / drug effects
Chemical
Reg. No./Substance:
0/Amyloid beta-Protein Precursor; 0/Neuroprotective Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A portable tactile sensory diagnostic device.
Next Document:  Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disor...